Comparison of speech and language therapy techniques for speech problems in Parkinson's disease
- 15 August 2012
- journal article
- research article
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2012 (8) , CD002814
Abstract
Patients with Parkinson's disease commonly suffer from speech and voice difficulties such as impaired articulation and reduced loudness. Speech and language therapy (SLT) aims to improve the intelligibility of speech with behavioural treatment techniques or instrumental aids. To compare the efficacy and effectiveness of novel SLT techniques versus a standard SLT approach to treat Parkinsonian speech problems. We identified relevant, published prior to 11(th) April 2011, by electronic searches of numerous literature databases including CENTRAL, MEDLINE and CINAHL, as well as handsearching relevant conference abstracts and examining reference lists in identified studies and other reviews. Only randomised controlled trials (RCT) of one type of speech and language therapy versus another were included. Two review authors independently extracted data and resolved differences by discussion. Six trials involving 159 patients satisfied the inclusion criteria. Data could not be analysed from one trial due to changes in patient numbers and from a second because the data provided were not in a usable format. All trials reported intelligibility measures but a statistically significant result was only reported for the diagnostic rhyme test used in the study of Lee Silverman Voice Treatment -LOUD (LSVT-LOUD) versus a modified version of this therapy (LSVT-ARTIC). In this case a difference of 12.5 points (95% confidence interval (CI) -22.2 to -2.8; P = 0.01) between the mean changes in favour of the LSVT-LOUD group was reported for a speech sample overlaid with Babble noise; this difference was not reproduced for the two additional noise conditions under which the speech samples were assessed. LSVT-LOUD also outperformed LSVT-ARTIC and Respiration therapy (RT) in improving loudness, with a difference in reading a sample text of 5.0 dB (95%CI -8.3 to -1.7; P = 0.003) and 5.5 dB (95% CI 3.4 to 7.7; P < 0.00001) respectively, and a difference in monologue speech of 2.9 dB (95% CI 0.6 to 5.2; P = 0.01) versus RT. Considering the small patient numbers in these trials, there is insufficient evidence to support or refute the efficacy of any form of SLT over another to treat speech problems in patients with Parkinson's disease.Keywords
This publication has 32 references indexed in Scilit:
- The effectiveness of traditional methods and altered auditory feedback in improving speech rate and intelligibility in speakers with Parkinson's diseaseInternational Journal of Speech-Language Pathology, 2010
- National survey of speech and language therapy provision for people with Parkinson's disease in the United Kingdom: therapists’ practicesInternational Journal of Language & Communication Disorders, 2010
- Survey of speech and language therapy provision for people with Parkinson's disease in the United Kingdom: patients' and carers' perspectivesInternational Journal of Language & Communication Disorders, 2010
- Quality of life in Polish patients with long‐lasting Parkinson's diseaseMovement Disorders, 2003
- Speech Loudness and Quality 12 Months after Intensive Voice Treatment (LSVT®) for Parkinson’s Disease: A Comparison with an Alternative Speech TreatmentFolia Phoniatrica et Logopaedica, 2002
- Intensive voice treatment (LSVT(R)) for patients with Parkinson's disease: a 2 year follow upJournal of Neurology, Neurosurgery & Psychiatry, 2001
- Improving the quality of reporting of randomized controlled trials. The CONSORT statementJAMA, 1996
- Review papers : The statistical basis of meta-analysisStatistical Methods in Medical Research, 1993
- The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1988
- Speech therapy for Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1983